Rapid Biotech education for busy professionals
Rapid Biotech education for busy professionals
• What makes a cell alive and healthy
• How are cancer cells different
• Birth, life and death of human cells
• The Hallmarks of cancer and the Immune system
• Carcinogenesis I: from a healthy to a cancer cell
• Carcinogenesis II: from a cancer cell to disease
• Self and non-self
• The clients: cells, viruses and macromolecules
• The providers: immune system cells, organs and signals
• Innate and adaptive immune responses
• Immuno-editing
• Inflammation: a double-edged sword
• Leukemias and lymphomas
• Tumor microenvironment
• From hybridomas to recombinant antibodies
• Immunodiagnostics in oncology
• Therapeutic antibodies
• Monoclonal antibodies
• Checkpoint inhibitors
• CART-cells and other adoptive cell transfer therapies
• Cytokines and adjuvants
• Cancer vaccines
• Oncolytic viruses
• Bi-specific T-cell engagers
• Combination therapies
• Immunotherapy-related Adverse Events
• Hyper –progressive disease
• Predicting efficacy and tumor heterogeneity
• Cancer immunoprevention
A two-day course made for all professionals– scientists and non-scientists- working in oncology.
Forty-seven years ago, US president Richard Nixon declared the War on Cancer. Many battles have been waged since that day, some were won, many were lost. And then came modern immunotherapies…
Will harnessing the immune system lead to cure against all cancers? No one knows, but immunotherapies are a game changer for more and more patients and the drug industry. In a very short time, more than 2000 drug discovery and development programs in immuno-oncology have been launched…
Is this a challenging development ? Of course. Complex? Certainly.
Fully understandable only by biomedical experts? Certainly not.
Not if you join our course!
Leveraging on our 12 year-long experience in transdisciplinary life science education aimed at busy professionals, this small group course acts as a springboard to explore with confidence all the sciences of immuno-oncology.
It defines with simplicity all the essential notions in biology, oncology and immunology to understand current developments in the field.
It makes the invisible world of disease mechanisms and associated immune responses visible and understandable.
It explains the modes of action of all current immunotherapies, the promises they hold but also the concerns and the challenges.
Vanya Loroch, PhD
Molecular Biologist, professional educator, science storyteller
focusing on cancer biology and immunology.
Current and former positions: University of California,
University of Geneva, Business School Lausanne, Swiss Biotech
Association Academy